Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blocking EGFR Activation with Anti‐EGF Nanobodies via Two Distinct Molecular Recognition Mechanisms

Published:2018-10-15 Issue:42 Volume:57 Page:13843-13847
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Guardiola Salvador¹,Varese Monica¹,Sánchez‐Navarro Macarena¹,Vincke Cécile²,Teixidó Meritxell¹,García Jesús¹,Muyldermans Serge²,Giralt Ernest¹³^ORCID

Affiliation:

1. Institute for Research in Biomedicine (IRB Barcelona)The Barcelona Institute of Science and Technology Baldiri Reixac, 10 08028 Barcelona Spain

2. Cellular and Molecular ImmunologyVrije Universiteit Brussel 1050 Brussels Belgium

3. Department of Inorganic and Organic ChemistryUniversity of Barcelona Spain

Funder

Ministerio de Economía, Industria y Competitividad, Gobierno de España

Generalitat de Catalunya

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.201807736

Reference23 articles.

1. A Structural Perspective on the Regulation of the Epidermal Growth Factor Receptor

2. Binding specificities and affinities ofegfdomains for ErbB receptors

3. Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence

4. A view on EGFR-targeted therapies from the oncogene-addiction perspective

5. ErbB receptors: from oncogenes to targeted cancer therapies

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer;Frontiers in Oncology;2024-04-30

2. Functionalized nanobody-based delivery systems for cancer diagnosis and therapeutic applications;Functionalized Nanomaterials for Cancer Research;2024

3. 20 years since the approval of first EGFR-TKI, gefitinib: Insight and foresight;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

4. Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library;Molecules;2023-05-12

5. Nanobodies in cell-mediated immunotherapy: On the road to fight cancer;Frontiers in Immunology;2023-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3